— Know what they know.
Not Investment Advice
Also trades as: OABIW (NASDAQ) · $vol 0M

OABI NASDAQ

OmniAb, Inc.
1W: +16.4% 1M: +70.0% 3M: +50.0% YTD: +35.6% 1Y: +65.6% 3Y: -33.4%
$2.65
+0.10 (+3.92%)
 
Weekly Expected Move ±11.9%
$2 $2 $2 $2 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 64 · $315.6M mcap · 83M float · 0.716% daily turnover · Short 50% of daily vol

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$19M -29.3% ▼
5Y CAGR: -4.3%
Gross Profit
-$3M -112.8% ▼
Operating Income
-$72M +4.0% ▲
Net Income
-$65M -4.4% ▼
EPS (Diluted)
$-0.57 +6.6% ▲
EBITDA
-$50M +2.3% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$35M$59M$34M$26M$19M
YoY Growth+49.3%+70.0%-42.2%-22.8%-29.3%
Cost of Revenue$0$0$0$0$22M
Gross Profit$35M$59M$34M$26M-$3M
Gross Margin100.0%100.0%100.0%100.0%-18.2%
R&D Expenses$39M$48M$57M$55M$48M
SG&A Expenses$17M$25M$33M$31M$29M
Operating Expenses$70M$86M$104M$101M$68M
Operating Income-$36M-$27M-$69M-$75M-$72M
Operating Margin-102.5%-45.1%-203.2%-282.3%-383.1%
Interest Expense$7K$0$0$0$0
Income Before Tax-$34M-$26M-$64M-$71M-$66M
Tax Expense-$7M-$4M-$14M-$9M-$2M
Net Income-$27M-$22M-$51M-$62M-$65M
Net Margin-77.8%-37.8%-148.2%-235.1%-347.0%
EPS (Diluted)$-0.24$-0.26$-0.51$-0.61$-0.57
EBITDA-$18M-$8M-$50M-$51M-$50M
Shares Outstanding115M85M100M102M114M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms